PharmD Info

A forum for Indian Pharmacy Professionals

Treatment Guidelines - Hospital Institutional Guidelines, Standard Treatment Guidelines, WHO Guidelines, Disease Treatment Guidelines and etc
Forum rules: The material, content provided by this forum is for informational purpose only and is not intended for substitute to medical advice, diagnosis or treatment.General rules are applicable for this forum- Find Here
  • User avatar
User avatar
By Admin
#198
The guideline introduces new standards for registering, monitoring and reporting outcomes of multidrug-resistant TB cases. This uniform information management system will allow systematic, consistent data collection and analysis which will facilitate appropriate supervision and monitoring of the DOTS Plus activities and will play an important role in
shaping future policies and recommendations.

Download Dots Plus
Attachments:
(573.47 KiB) Downloaded 285 times
Similar Topics
Topics Statistics Last post
ICH E-19 New Guidelines - What's New?
by Admin    - In: ICH-GCP Guidelines
0 Replies 
906 Views
by Admin
FDA SUPAC- IR,MR and SS Guidelines
by Admin    - In: FDA Guidelines
0 Replies 
1538 Views
by Admin
0 Replies 
1535 Views
by Admin
0 Replies 
538 Views
by Admin
List of ICH Guidelines - Safety Topics
by Admin    - In: ICH-GCP Guidelines
0 Replies 
1537 Views
by Admin

Embarking on a profession in pharmacy involves no […]

Tamoxifen remains active for up to two weeks after[…]

Pharmacy practice in India is a dynamic and rapidl[…]

PBMs, or Pharmacy Benefit Managers, are businesses[…]

PharmD Info - Highlights